MD Douglas Reed G1 Therapeutics, Inc
As of June 1, 2018
MD Douglas Reed Net Worth
- Net worth is estimated to be at least $98.78M
- Owns at least 3,237,711 units of G1 Therapeutics, Inc stock
- Sold an estimated value of $40.32M in the last year at G1 Therapeutics, Inc
MD Douglas Reed Trading
- Largest purchase of shares was 4,173,729 units , worth over $2M on May 24, 2017
- Largest sale of shares was 800,000 units , worth over $38.4M on June 1, 2018
- In total has made about 4 transactions over a year
- Usually trades in May, with the busiest year in 2017 and 2018
Clay Thorp, Hatteras Venture Advisors IV SBIC LLC, Hatteras Venture Partners IV SBIC LP, ALEXANDER ROBERT INGRAM, John Crumpler, KENNETH LEE JR, MD Douglas Reed
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
MD Douglas Reed Mailing Address
- Mailing address is C/o Vector Fund Management 1751 Lake Cook Road, Suite 350 Deerfield IL 60015 IL
G1 Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| John E. Bailey, Jr. | 2020 | - | $542,109 | - | $215,948 | $758,057 |
| Mark A. Velleca, M.D., Ph.D. | 2020 | $608,308 | $3,069,704 | $305,000 | $8,550 | $3,991,562 |
| Mark A. Velleca, M.D., Ph.D. | 2019 | $589,700 | $3,105,237 | $280,108 | $8,400 | $3,983,445 |
| Mark A. Velleca, M.D., Ph.D. | 2018 | $515,000 | $1,044,529 | $321,875 | $33,250 | $1,914,654 |
| Jennifer K. Moses | 2020 | $398,583 | $1,116,239 | $141,050 | $8,550 | $1,664,422 |
| Jennifer K. Moses | 2019 | $315,598 | $972,601 | $117,600 | $8,400 | $1,414,199 |
| Mark Avagliano | 2020 | $431,417 | $837,165 | $151,200 | $18,445 | $1,438,227 |
| Mark Avagliano | 2019 | $181,913 | $5,100,560 | $142,800 | $53,117 | $5,478,390 |
| Rajesh K. Malik, M.D. | 2020 | $424,000 | $836,733 | $148,750 | $8,550 | $1,418,033 |
| Rajesh K. Malik, M.D. | 2019 | $413,000 | $828,195 | $138,768 | $8,400 | $1,388,363 |
| Rajesh K. Malik, M.D. | 2018 | $400,000 | $696,968 | $169,400 | $8,250 | $1,274,618 |
| Soma Gupta | 2020 | $320,360 | $2,212,758 | $114,662 | $100,000 | $2,747,780 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1560241/000119312521136977/d122680ddef14a.htm
G1 Therapeutics, Inc Insider Trading
- The most recent transaction was 30,000 units sold on July 15, 2021 by Mark Velleca worth over $570.26K
- In the last 4 years, insiders at G1 Therapeutics, Inc sold an estimated value of $67.24M and bought an estimated value of $25.67M
- The most active traders are Rajesh Malik, Chief Medical Officer, Mark Velleca, and Jennifer Moses, CFO
- Insider trading is most common in June, with the busiest year in 2018
G1 Therapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||